nach oben

Erschienen in:

30.03.2019 | Original Paper

Metabolic Syndrome Among People Living with HIV Receiving Medical Care in Southern United States: Prevalence and Risk Factors

verfasst von: Sabeena Sears, Justin R. Buendia, Sylvia Odem, Mina Qobadi, Pascale Wortley, Osaro Mgbere, Jontae Sanders, Emma C. Spencer, Arti Barnes

Erschienen in: AIDS and Behavior | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Using representative data among 1861 in care people living with HIV (PLWH) in four southern states (Texas, Mississippi, Florida, and Georgia) from the 2013–2014 Medical Monitoring Project (MMP) survey, we estimated the prevalence and odds of metabolic syndrome (MetS) among various demographic and HIV related risk factors. Overall MetS prevalence was 34%, with our participants being mostly black (55%), male (72%), ≥ 50 years old (46%), and overweight or obese (60%) with undetectable viral loads (≤ 200 copies/ml, 69%), and were currently taking antiretroviral medication (98%). Compared to those who were ≥ 60 years, 18–39 year olds had a 79% (95% CI 0.13–0.33) lower odds of having MetS. Women were 2.24 times more likely to have MetS than men (95% CI 1.69–2.97). Age and sex were significant predictors of MetS. Since MetS is a combination of chronic disease risk factors, regular screening for MetS risk factors among aging PLWH is crucial.

Grinsztejn B, Luz PM, Pacheco AG, et al. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS ONE. 2013;8(4):e59768.PubMedPubMedCentralCrossRef

Martin-Iguacel R, Negredo E, Peck R, Friis-Møller N. Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV. Curr Hypertens Rep. 2016;18(6):46.PubMedPubMedCentralCrossRef

Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005–70.PubMedPubMedCentralCrossRef

Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853–60.PubMedCrossRef

Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486.CrossRef

Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–78.PubMedCrossRef

Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–28.CrossRefPubMed

Sperling LS, Mechanick JI, Neeland IJ, et al. The cardiometabolic health alliance: working toward a new care model for the metabolic syndrome. J Am Coll Cardiol. 2015;66(9):1050–67.PubMedCrossRef

Paula AA, Falcão MC, Pacheco AG. Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects. AIDS Res Ther. 2013;10(1):32.PubMedPubMedCentralCrossRef

10.

Branson BM, Owen SM, Wesolowski LG, et al. Laboratory testing for the diagnosis of HIV infection: updated recommendations. 2014.

11.

Jaggers JR, Prasad VK, Dudgeon WD, et al. Associations between physical activity and sedentary time on components of metabolic syndrome among adults with HIV. AIDS Care. 2014;26(11):1387–92.PubMedPubMedCentralCrossRef

12.

Jericó C, Knobel H, Montero M, et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care. 2005;28(1):132–7.PubMedCrossRef

13.

Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141–55.PubMedPubMedCentralCrossRef

14.

Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Aids. 1998;12(7):F51–8.PubMedCrossRef

15.

Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.PubMedPubMedCentralCrossRef

16.

Farahani M, Mulinder H, Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017;28(7):636–50.PubMedCrossRef

17.

Data Collection on Adverse Events of Anti-HIV drugs (D: A: D) Study Group. Factors associated with specific causes of death amongst HIV-positive individuals in the D: A: D Study. Aids. 2010;24(10):1537–48.CrossRef

18.

Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993–2003.PubMedCrossRef

19.

Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–12.PubMedCrossRef

20.

Lang S, Mary-Krause M, Cotte L, et al. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case–control study nested within the French Hospital Database on HIV ANRS cohort CO4. Arch Intern Med. 2010;170(14):1228–38.PubMedCrossRef

21.

Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a U.S. Health Care System. J Acquir Immune Defic Syndr (1999). 2012;60(4):351–8.CrossRef

22.

CfD Control. Prevention. National diabetes statistics report, 2017. Atlanta, GA: Centers for Disease Control and Prevention; 2017. p. 2017.

23.

Tien PC, Schneider MF, Cox C, et al. Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetes. J Acquir Immune Defic Syndr (1999). 2012;61(3):334.CrossRef

24.

Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165(10):1179–84.PubMedCrossRef

25.

Butt AA, McGinnis K, Rodriguez-Barradas MC, et al. HIV infection and the risk of diabetes mellitus. AIDS (London, England). 2009;23(10):1227.PubMedCentralCrossRef

26.

Samaras K. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. JAIDS J Acquir Immune Defic Syndr. 2009;50(5):499–505.PubMedCrossRef

27.

Rasmussen LD, Mathiesen ER, Kronborg G, Gerstoft J, Obel N. Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study. PLoS ONE. 2012;7(9):e44575.PubMedPubMedCentralCrossRef

28.

Rebeiro PF, Gange SJ, Horberg MA, et al. Geographic variations in retention in care among HIV-infected adults in the United States. PLoS ONE. 2016;11(1):e0146119.PubMedPubMedCentralCrossRef

29.

Ezzati M, Martin H, Skjold S, Hoorn SV, Murray CJ. Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med. 2006;99(5):250–7.PubMedPubMedCentralCrossRef

30.

Danaei G, Friedman AB, Oza S, Murray CJ, Ezzati M. Diabetes prevalence and diagnosis in US states: analysis of health surveys. Popul Health Metr. 2009;7(1):16.PubMedPubMedCentralCrossRef

31.

Hicks LS, Fairchild DG, Cook E, Ayanian JZ. Association of region of residence and immigrant status with hypertension, renal failure, cardiovascular disease, and stroke, among African-American participants in the third National Health and Nutrition Examination Survey (NHANES III). Ethn Dis. 2003;13(3):316–23.PubMed

32.

Obisesan TO, Vargas CM, Gillum RF. Geographic variation in stroke risk in the United States: region, urbanization, and hypertension in the Third National Health and Nutrition Examination Survey. Stroke. 2000;31(1):19–25.PubMedCrossRef

33.

Reif SS, Whetten K, Wilson ER, et al. HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care. 2014;26(3):351–9.PubMedCrossRef

34.

Reif S, Safley D, McAllaster C, Wilson E, Whetten K. State of HIV in the US Deep South. J Community Health. 2017;42(5):844–53.PubMedCrossRef

35.

AIDSVu. Emory University, Rollins School of Public Health; 2014. https://aidsvu.org/. Accessed 22 Jan 2019.

36.

Iachan R, Johnson CH, Harding RL, et al. Design and weighting methods for a nationally representative sample of HIV-infected adults receiving medical care in the United States-Medical Monitoring Project. Open AIDS J. 2016;10:164.PubMedPubMedCentralCrossRef

37.

Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diab Med. 2006;23(5):469–80.CrossRef

38.

Bozeman SR, Hoaglin DC, Burton TM, Pashos CL, Ben-Joseph RH, Hollenbeak CS. Predicting waist circumference from body mass index. BMC Med Res Methodol. 2012;12(1):115.PubMedPubMedCentralCrossRef

39.

Bernal E, Masia M, Padilla S, Martin-Hidalgo A, Gutierrez F. Prevalence and characteristics of metabolic syndrome among HIV-infected patients from a Mediterranean cohort. Med Clin. 2007;128(5):172–5.CrossRef

40.

Gazzaruso C, Bruno R, Garzaniti A, et al. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens. 2003;21(7):1377–82.PubMedCrossRef

41.

Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia. Diabetes Care. 2007;30(1):113–9.PubMedCrossRef

42.

Nguyen KA, Peer N, de Villiers A, et al. Metabolic syndrome in people living with human immunodeficiency virus: an assessment of the prevalence and the agreement between diagnostic criteria. Int J Endocrinol. 2017;2017:1613657.PubMedPubMedCentralCrossRef

43.

Jacobson DL, Tang AM, Spiegelman D, et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr (1999). 2006;43(4):458–66.CrossRef

44.

Freimer N, Echenberg D, Kretchmer N. Cultural variation—nutritional and clinical implications. West J Med. 1983;139(6):928–33.PubMedPubMedCentral

45.

Nicolson TJ, Mellor HR, Roberts RR. Gender differences in drug toxicity. Trends Pharmacol Sci. 2010;31(3):108–14.PubMedCrossRef

46.

Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32(1):130–9.PubMedCrossRef

47.

Cerrato E, Calcagno A, D’Ascenzo F, et al. Cardiovascular disease in HIV patients: from bench to bedside and backwards. Open Heart. 2015;2(1):e000174.PubMedPubMedCentralCrossRef

48.

Pernerstorfer-Schoen H, Jilma B, Perschler A, et al. Sex differences in HAART-associated dyslipidaemia. Aids. 2001;15(6):725–34.PubMedCrossRef

49.

Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. Arch Fam Med. 2000;9(6):506.PubMedCrossRef

50.

Sobieszczyk ME, Hoover DR, Anastos K, et al. Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr (1999). 2008;48(3):272–80.CrossRef

51.

Polotsky HN, Polotsky AJ, editors. Metabolic implications of menopause. Seminars in reproductive medicine; 2010. Stuttgart: Thieme Medical Publishers; 2010.

52.

Akl L, Valadares A, Gomes D, Pinto-Neto A, Costa-Paiva L. Factors associated with metabolic syndrome in middle-aged women with and without HIV. J Metabolic Syndr. 2016;5(200):2167-0943.1000.

53.

Tremollieres FA, Pouilles J-M, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol. 1996;175(6):1594–600.PubMedCrossRef

Titel: Metabolic Syndrome Among People Living with HIV Receiving Medical Care in Southern United States: Prevalence and Risk Factors
verfasst von: Sabeena Sears
Justin R. Buendia
Sylvia Odem
Mina Qobadi
Pascale Wortley
Osaro Mgbere
Jontae Sanders
Emma C. Spencer
Arti Barnes
Publikationsdatum: 30.03.2019
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 11/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-019-02487-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Evaluation of Sex Positive! A Video eHealth Intervention for Men Living with HIV

The Relationship Between Economic Deprivation, Housing Instability and Transactional Sex Among Women in North Carolina (HPTN 064)

Love with No Exceptions: A Statewide Faith-Based, University–Community Partnership for Faith-Based HIV Training and Assessment of Needs in the Deep South

Ending HIV in America: Not Without the Power of Community

High Levels of Syndemics and Their Association with Adherence, Viral Non-suppression, and Biobehavioral Transmission Risk in Miami, a U.S. City with an HIV/AIDS Epidemic